State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Science, Chinese Academy of Sciences, Beijing, China.
Weifang Medical University, Weifang, China.
Am J Hematol. 2019 Feb;94(2):184-188. doi: 10.1002/ajh.25341. Epub 2018 Nov 26.
During pregnancy, iron requirements are increased to support maternal erythropoietic expansion and fetal growth and development. To meet these requirements, dietary iron absorption increases, and available iron stores are mobilized. These adjustments are thought to be in large part mediated by the iron-regulatory hormone hepcidin, which controls the concentrations of ferroportin, the sole exporter of iron into the extracellular fluid and blood plasma. Hepcidin regulation of iron availability during healthy and abnormal pregnancies is not well understood. In our cross-sectional study, we compared hepcidin, iron and hematological parameters between nonpregnant control women, healthy pregnant women in the first and second trimester, and women with spontaneous abortion in the first trimester. We found that in healthy pregnancy, hepcidin increased in the first trimester compared with nonpregnant women, but then decreased during the second trimester. The second trimester hepcidin levels decreased despite stable serum iron concentrations, suggesting active suppression of hepcidin, presumably to enhance iron availability as iron demand increases. In women with spontaneous abortion during the first trimester, hepcidin, serum iron, and ferritin concentrations were all increased compared with the first trimester healthy pregnancy. Although the specific mechanisms remain to be determined, our findings demonstrate that maternal hepcidin is regulated by signals related to the progression of pregnancy, and that pregnancy loss is associated with profound changes in maternal iron metabolism. These observations highlight the existence of fetoplacental signals that modulate maternal iron homeostasis.
在怀孕期间,铁的需求量增加以支持母体红细胞生成和胎儿的生长发育。为了满足这些需求,膳食中铁的吸收增加,可用的铁储存被动员。这些调整被认为在很大程度上是由铁调节激素铁调素介导的,铁调素控制着铁向细胞外液和血浆输出的唯一出口——亚铁转运蛋白的浓度。铁调素对健康和异常妊娠期间铁的可用性的调节尚不清楚。在我们的横断面研究中,我们比较了非妊娠对照组妇女、健康妊娠第一和第二孕期妇女以及第一孕期自然流产妇女之间的铁调素、铁和血液学参数。我们发现,在健康妊娠中,铁调素在第一孕期与非妊娠妇女相比增加,但随后在第二孕期下降。尽管血清铁浓度稳定,但第二孕期铁调素水平下降,表明铁调素被积极抑制,可能是为了增加铁的可用性,因为铁的需求增加。在第一孕期自然流产的妇女中,与第一孕期健康妊娠相比,铁调素、血清铁和铁蛋白浓度均升高。尽管具体机制仍有待确定,但我们的研究结果表明,母体铁调素受与妊娠进展相关的信号调节,妊娠丢失与母体铁代谢的深刻变化有关。这些观察结果强调了存在调节母体铁稳态的胎-胎盘信号。